Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2

por Jaggaiahgari, Shashidhar, Munigela, Apoorva, Mitnala, Sasikala, Gujjarlapudi, Deepika, Simhadri, Venu, D, Nageshwar Reddy
Publicado 2022

Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors

por Deshpande, Neha, V., Sharanya, V. V., Ravi Kanth, H. V. V., Murthy, M., Sasikala, Banerjee, Rupa, Tandan, Manu, D., Nageshwar Reddy
Publicado 2016